Chairman’s message
The Department of Neurology at Yale University is a world-renowned research, teaching, and clinical center dedicated to excellence in patient care. teaching medical and graduate students; and neurological research. We are proud to report our continued growth in our 2020-2022 Annual Report.
The tireless efforts of our 138 faculty and staff have increased the overall age percentage of active grants, ultimately ranking us sixth in total NIH funding for neurology in 2021. Despite restrictions due to COVID-19, Neurology has once again recruited a new resident in a class of excellence. Our clinical research continues to expand into southern New England.
Our department has made breakthroughs in clinical and basic neurological research. Key achievements include the Alzheimer’s Disease Research Award and the Human Immunology Project Consortium Grant. Two separate her $9 million ASAP grants to investigate Parkinson’s disease. Genentech awarded a $22 million investigator-led grant to study early immune interventions for patients with multiple sclerosis. We have integrated our translational and research efforts with basic science across neuroscience, cell biology, and inflammation in connection with the new Wu Tsai Institute for studying human cognition. We also continue to expand our NIH-funded clinical trial network. NeuroNEXT Infinity, StrokeNET Spirit, and ASPIRE, an anticoagulant Phase III clinical trial.
Our faculty continues to play a pivotal role in training the next generation of neurologists. Neurology has adopted a hybrid virtual and face-to-face teaching model during the pandemic, enabling enhanced teaching and learning tools for residents and clinical fellows. The virtual format was also extended to recruitment, with over 550 residency applications. The Virtual Grand Round used the Zoom format to welcome prominent speakers from Japan and abroad. This wealth of expertise and perspective facilitates more comprehensive discussions and has proven to be an integral part of our medical education program.
Neurology continues its massive expansion in Connecticut and neighboring states. Comprehensive Neurology, Headache, Stroke, Epilepsy, Memory Disorder, Neuromuscular Medicine (including EMG) as well as a new infusion center established at an outpatient clinic in Fairfield, Connecticut. Under the guidance of Serena Spudich, MD, MA, developed her one of the first clinics in the United States dedicated to the diagnosis and management of neurological complications. COVID-19 and hospital services have reached or exceeded pre-COVID-19 levels. A second neurointensive care team is now offering consultations to post-cardiac arrest patients. Under the leadership of Emily Gilmore, M.D., and Sasit Brent Omey, M.D., a multidisciplinary neurotrauma service has been established to care for brain trauma patients from the point of acute injury through outpatient follow-up. Our neurovascular services have been split into two teams to accommodate the growing number of acute stroke codes within Yale New Haven Hospitals (YNHH) and remote strokes at her one of 10 spoke hospitals. rice field.
We have also enhanced the care we provide in our general neurology services by adding two advanced practice providers to our team. Neurology inpatient-based services are now available at five of his six YNHHS hospitals. The latest addition is the Neurology Program at Bridgeport Hospital. A stroke intervention program was established at Greenwich Hospital in collaboration with Neurosurgery. Bridgeport Hospital recently started his third stroke program, treating the first patient.
I hope this annual report provides a complete picture of our values, our dedication to the pursuit of knowledge, and our care for the communities we serve. We thank all members of the department for their support and look forward to continued success in the coming year.
Sincerely,
David A. Hafler, M.D.
William S. and Lois Stiles Edgerley Professor of Neurology and Professor of Immunobiology
Head of Neurology
Chief of Neurology, Yale-New Haven Hospital
